Healthcare is more than coverage alone. It is being there when people need you most and helping in ways they never imagined while keeping our commitment to affordability for employers.
Emerging gene therapies show great promise for treatment of difficult, rare conditions but at significant cost. Our Gene Therapy Solution works as an endorsement of our stop loss policy to protect employers from unknown financial risk while providing access to robust care management for individuals with rare and complex conditions.
Access to life-changing therapies and whole-health support for your employees while protecting your bottom line
Gene therapy solutions
Learn about gene therapy
Gene therapy is an evolving treatment for rare disorders caused by a missing or faulty gene and may involve addition, inhibition, editing, or replacement of a gene. Gene therapies can be one-time treatments that target the genetic root cause of diseases.
The rising impact of gene therapy*
12
143,000
Year to date
>6.1M
26
End of 2026
>42x
>3x growth
End of 2027
* Internal analysis, CarelonRx, March 2025.
1 American Society of Gene + Cell Therapy (ASGCT): Gene, Cell, and RNA Therapy Landscape Report: Q1 2025 Quarterly Data Report (accessed July 2024): asgct.org.
For self funded plans, claims are administered by Wellpoint Life and Health Insurance Company. Insurance coverage is provided by Wellpoint Life and Health Insurance Company.
1043338MUEENWLP 04/25
To learn more about our Gene Therapy Solution, contact your Wellpoint representative.
Together, we can make a difference in improving health outcomes for your employees while protecting your business from the high costs associated with rare and complex conditions.
Future gene therapies include treatments for blood disorders, such as hemophilia, sickle cell anemia, and other diseases.
Wellpoint will monitor developments in gene therapies as we continue to advocate for high-value treatments for employees while controlling costs for employers.
The future of gene therapy
What is gene therapy?
Gene therapy is an evolving treatment for rare disorders caused by a missing or faulty gene. It may involve addition, inhibition, editing, or functional replacement of a gene. Gene therapies can be one-time treatments and target the genetic root cause of the disease. These treatments are administered in hospitals as infusions, so they fall under medical coverage instead of pharmacy.
As an endorsement of our stop loss policy, our Gene Therapy Solution protects employers from unknown financial risk while offering their employees and family members access to emerging clinical treatments.
